Digital health pioneers target NHS heart monitoring with expanded partnership

HASSELT – February 21, 2025 – Digital health pioneers Inhealthcare and FibriCheck today announced the expansion of their partnership to bring hospital-grade heart monitoring into patients’ homes through NHS virtual ward pathways.

Inhealthcare has developed more than 150 clinically designed digital health services used by four million patients across the UK during its decade of NHS experience. FibriCheck, celebrating its own 10-year milestone, has pioneered smartphone-based heart monitoring and is now trusted by more than 2,500 clinicians and hospitals across 43 countries. Together, they combine proven remote monitoring expertise with medical-grade heart rhythm technology.

The partnership addresses growing healthcare pressure, with cardiovascular disease affecting seven million people in the UK and costing the NHS £7.4 billion annually. Through Inhealthcare’s platform, clinicians can seamlessly access FibriCheck’s monitoring data via their existing systems, enabling timely intervention and optimal resource allocation. 

FibriCheck empowers clinical decision-making by providing longitudinal data through heart rhythm and heart rate measurements. Users can log symptoms alongside each measurement, adding valuable context to the data and enabling symptom-rhythm insights. FibriCheck delivers exceptional accuracy, with clinical studies reporting 98.3 per cent sensitivity, 99.9 per cent specificity, and 97 per cent overall accuracy. It also outperforms consumer wearables, demonstrating significantly higher detection rates for atrial arrhythmias compared to traditional methods. Additionally, the app stands out for its user-friendliness, with 91 per cent of survey respondents rating it as ‘very easy’ or ‘easy’ to use.

As a first step in their collaboration, FibriCheck and Inhealthcare are partnering with NHS Scotland to integrate FibriCheck into the Connect-Me platform. The technology could easily be scaled to other NHS services, enabling patients all over the UK to access heart rhythm measurements easily. 

Implementations of FibriCheck within NHS trusts have demonstrated significant impact, as published findings from multiple trusts reveal £1,000 in cost savings per patient and a four-day reduction in average bed days. Additionally, the technology has contributed to reduced healthcare utilization by decreasing the need for ECGs and Holter monitors, minimizing patient travel times, and freeing up clinical capacity through more efficient outpatient workflows. These results highlight the potential for FibriCheck to improve patient outcomes while optimizing NHS resources.

About Inhealthcare

Inhealthcare is a UK leader in digital health and remote patient monitoring. The Harrogate, North Yorkshire-based company has serviced more than four million episodes of care and produced more than 150 separate digital pathways. Inhealthcare supports more than 50 NHS trusts in England, the five health and social care trusts in Northern Ireland and has a national agreement with NHS National Services Scotland to deliver services across the 12 health boards. Inhealthcare’s digital health services are co-designed with clinicians with input from users. The company works with NHS organisations to develop new pathways and has a library of more than 150 existing services. These can be adapted to meet the needs of local populations.

Inhealthcare supports vulnerable high-risk patients, including those in care homes, and patients with long-term conditions such as respiratory diseases and heart failure. The company also supports patients with short-term conditions including hypertension. Inhealthcare is part of ResMed, a global leader in digital health and cloud-connected medical devices, founded on the purpose of empowering people to live healthier, higher-quality lives.

For more information about Inhealthcare, please visit www.inhealthcare.co.uk

About FibriCheck

FibriCheck’s medically certified (CE1639) technology consists of a user-facing application, an extensively validated AI algorithm and a portal for healthcare providers. Throughout the entire patient life cycle, FibriCheck’s technology redefines the way cardiac arrhythmias are detected and managed. At the same time it empowers people to take control of their heart health by enabling them to measure their heart rate and heart rhythm in 60 seconds, using nothing but the camera of their smartphone without any additional hardware. With these measurements, FibriCheck aims to improve the outcomes of cardiac arrhythmias by speeding up the process of getting the right diagnosis and treatment.